I have some ideas as to why cvm could be perceived as undervalued (excluding positive or negative results); but I don’t see cvm shareholders participating in the event of poor results.
Where are you allocating value to cvm (excluding results)? Or is all your value baked in speculation? And the assumption of positive results?